Tumor-derived exosomes: A message delivery system for tumor progression.
about
Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunityThe potential of tumor-derived exosomes for noninvasive cancer monitoringImmunotherapeutic potential of extracellular vesiclesExocytosis and Endocytosis of Small Vesicles across the Plasma Membrane in Saccharomyces cerevisiaeHigh-efficiency Generation of Multiple Short Noncoding RNA in B-cells and B-cell-derived Extracellular Vesicles.Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune SuppressionExtracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myelomaRapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins.Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classificationExtracellular vesicle microRNAs mediate skeletal muscle myogenesis and diseaseIdentification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer.Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitroStem cell delivery of therapies for brain disorders.The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.Proteomic approach to understand metastatic spread.Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media From Human Osteosarcoma Cell Lines Reveals Secretion of Proteins Related to Tumor Progression.Natural extracellular nanovesicles and photodynamic molecules: is there a future for drug delivery?MicroRNAs contribution in tumor microenvironment of esophageal cancer.Tumor-Derived Exosomes and Their Role in Cancer Progression.Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready?Exosomes carrying immunoinhibitory proteins and their role in cancer.Targeting adenosine in cancer immunotherapy: a review of recent progress.Immunoglobulin Free Light Chains and GAGs Mediate Multiple Myeloma Extracellular Vesicles Uptake and Secondary NfκB Nuclear Translocation.Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.Profiling of plasma-derived extracellular vesicles cargo for diagnosis of pancreatic malignancy.The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy.Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression.DNM3, p65 and p53 from exosomes represent potential clinical diagnosis markers for glioblastoma multiforme.Biomarker discovery for renal cancer stem cells.Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma.Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management.CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
P2860
Q26782131-43DBAB42-0172-46D0-8D67-DAD3775870BFQ26796396-21D76EA3-F671-47AD-A39A-0CD8C6D42892Q27023323-3FCF6179-CF54-439E-A090-9666B46392F9Q27025552-69BDA444-9EA5-4894-8262-58DF738687FFQ27317402-27E717FB-4909-4A0C-A8AD-E878DD615B35Q28076769-E1F4FFD5-F378-4112-951F-96F9701CFFF9Q28077635-44FD2C7C-CB5B-46F1-8DE6-3EF7DA655231Q34362246-C0AE3BEA-B46C-4A8A-A98D-122B2DDB1B4EQ35273351-E207E8E0-450D-4AAE-9BA4-E791CE7D3361Q35692600-10B5B5D5-2C44-4556-A44E-4A7410F345B3Q36074100-91529ABA-3A6D-4694-9C30-D464BF323DDFQ36319389-67BF0662-C65C-48B2-89CA-64F7EE1B0121Q36331875-F3C162E2-16B2-4EB9-A269-67CACDEC7A04Q37204128-E604004F-D8B1-4DD3-AB4C-5D7EE1C9A6A8Q37269014-46C02DB3-008C-48F5-BA56-3835D43C947AQ37302281-1100961D-D453-4716-A641-7270C6F051D1Q38237392-A23C8EEE-A2F7-416E-937A-E52449B38019Q38238094-566C2657-75C6-467F-9DCB-53E48966364DQ38443346-58E35374-98C4-461E-B71B-60F146B49DD0Q38445377-FA0718CD-690C-4DC5-A053-955705EC749BQ38657626-8AA1247B-B123-49A5-8C5D-DF1D61E4D90CQ38793194-A89535F3-6D6B-4F06-82CE-0EC6FE2AE2F7Q38818439-18090AA3-6078-4F0B-ACC5-1A3F587037F4Q38886247-84B283BD-21D1-49C2-83C1-F553D7CE9B59Q39215663-0B698E2E-F636-47C3-BED9-585815301177Q39235260-D9D98CC6-2C36-4B94-84BA-D6EFA941F756Q42962110-2DF3C5DE-B4F8-476F-8C77-440AF0275365Q45872562-482476B4-0C58-4C15-8318-3E400966CAACQ47144938-7F97B84F-E8E0-4730-A2EA-0CCBBDC6F8A5Q47337961-77B1F3F1-AB82-4F4C-9937-4D3BC3DDC376Q49592892-2A8FF535-A3E2-4C4B-9762-BC2EC327EC69Q49956296-E19C11C9-2309-40E8-A0E4-6877520ACCE4Q50049701-7B98EF8A-C436-4B98-AC9C-7B9AA2178AC4Q55030529-3CE9AB77-592B-408F-86F0-E31F96B27DB4Q55342189-63C05300-6AEB-4F3E-AEAF-C50020055CE0Q58697956-A82C850C-8524-4D3E-A656-A91AAE0A7F15
P2860
Tumor-derived exosomes: A message delivery system for tumor progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-derived exosomes: A message delivery system for tumor progression.
@en
Tumor-derived exosomes: A message delivery system for tumor progression.
@nl
type
label
Tumor-derived exosomes: A message delivery system for tumor progression.
@en
Tumor-derived exosomes: A message delivery system for tumor progression.
@nl
prefLabel
Tumor-derived exosomes: A message delivery system for tumor progression.
@en
Tumor-derived exosomes: A message delivery system for tumor progression.
@nl
P2860
P356
P1476
Tumor-derived exosomes: A message delivery system for tumor progression
@en
P2093
Andrew K Godwin
P2860
P304
P356
10.4161/CIB.28231
P50
P577
2014-01-01T00:00:00Z